{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:21:15Z","timestamp":1790536875833,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Vaccine adjuvants from natural resources have been utilized for enhancing vaccine efficacy against infectious diseases. This study examined the potential use of catechins, polyphenolic materials derived from green tea, as adjuvants for subunit and inactivated vaccines. Previously, catechins have been documented to have irreversible virucidal function, with the possible applicability in the inactivated viral vaccine platform. In a mouse model, the coadministration of epigallocatechin-3-gallate (EGCG) with influenza hemagglutinin (HA) antigens induced high levels of neutralizing antibodies, comparable to that induced by alum, providing complete protection against the lethal challenge. Adjuvant effects were observed for all types of HA antigens, including recombinant full-length HA and HA1 globular domain, and egg-derived inactivated split influenza vaccines. The combination of alum and EGCG further increased neutralizing (NT) antibody titers with the corresponding hemagglutination inhibition (HI) titers, demonstrating a dose-sparing effect. Remarkably, EGCG induced immunoglobulin isotype switching from IgG1 to IgG2a (approximately &amp;gt;64\u2013700 fold increase), exerting a more balanced T<jats:sub>H<\/jats:sub>1\/T<jats:sub>H<\/jats:sub>2 response compared to alum. The upregulation of IgG2a correlated with significant enhancement of antibody-dependent cellular cytotoxicity (ADCC) function (approximately 14 fold increase), providing a potent effector-mediated protection in addition to NT and HI. As the first report on a novel class of vaccine adjuvants with built-in virucidal activities, the results of this study will help improve the efficacy and safety of vaccines for pandemic preparedness.<\/jats:p>","DOI":"10.3389\/fimmu.2021.769088","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T04:46:04Z","timestamp":1636692364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant"],"prefix":"10.3389","volume":"12","author":[{"given":"Yucheol","family":"Cheong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongkwan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonil","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanguine","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baik Lin","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0243-3","article-title":"Novel Vaccine Technologies for the 21st Century","volume":"20","author":"Mascola","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3409","article-title":"Key Roles of Adjuvants in Modern Vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.21","article-title":"Trends in Vaccine Adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.02.007","article-title":"Adjuvant Effect of Cationic Liposomes and CpG Depends on Administration Route","volume":"154","author":"Slutter","year":"2011","journal-title":"J Control Release"},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coph.2018.03.014","article-title":"Adjuvant Strategies to Improve Vaccination of the Elderly Population","volume":"41","author":"Weinberger","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: Classification, Modus Operandi, and Licensing","volume":"2016","author":"Apostolico Jde","year":"2016","journal-title":"J Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.141","article-title":"Monovalent Inactivated Split-Virion AS03-Adjuvanted Pandemic Influenza A (H1N1) Vaccine","volume":"9","author":"Walker","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018758431","article-title":"Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine","volume":"52","author":"James","year":"2018","journal-title":"Ann Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.2.133","article-title":"New Hepatitis B Vaccine Formulated With an Improved Adjuvant System","volume":"6","author":"Kundi","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747150","article-title":"The Vaccine Adjuvant Alum Promotes IL-10 Production That Suppresses Th1 Responses","volume":"48","author":"Oleszycka","year":"2018","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21143","article-title":"Inhibition of Aggregation of Aluminum Hydroxide Adjuvant During Freezing and Drying","volume":"97","author":"Clausi","year":"2008","journal-title":"J Pharm Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9859-5","article-title":"MF59 Emulsion is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)","volume":"26","author":"Baudner","year":"2009","journal-title":"Pharm Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination Adjuvants for the Induction of Potent, Long-Lasting Antibody and T-Cell Responses to Influenza Vaccine in Mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.vaccine.2012.10.096","article-title":"T Cell Vaccinology: Exploring the Known Unknowns","volume":"31","author":"Burchill","year":"2013","journal-title":"Vaccine"},{"key":"B15","author":"Abbas","year":"2012","journal-title":"Cellular and Molecular Immunology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.029","article-title":"Evaluation of T Helper-1\/-2 Balance on the Basis of IgG Subclasses and Serum Cytokines in Children With Glomerulonephritis","volume":"44","author":"Kawasaki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/BF01543103","article-title":"Biology of Human TH1 and TH2 Cells","volume":"15","author":"Romagnani","year":"1995","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/08830189709045703","article-title":"IgG Binding Sites on Human Fc Gamma Receptors","volume":"16","author":"Tamm","year":"1997","journal-title":"Int Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00207","article-title":"AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB\/c Mice","volume":"6","author":"Yam","year":"2015","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting Endotoxin to Work for Us: Monophosphoryl Lipid A as a Safe and Effective Vaccine Adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2.2.305","article-title":"CpG DNA as a Vaccine Adjuvant","volume":"2","author":"Klinman","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00077-E","article-title":"Structure\/function Studies of QS-21 Adjuvant: Assessment of Triterpene Aldehyde and Glucuronic Acid Roles in Adjuvant Function","volume":"13","author":"Soltysik","year":"1995","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2051013617691041","article-title":"Utilization of Cholera Toxin B as a Mucosal Adjuvant Elicits Antibody-Mediated Protection Against s. pneumoniae infection in mice","volume":"5","author":"Wiedinger","year":"2017","journal-title":"Ther Adv Vaccines"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1833579","article-title":"Exploring the Possible Use of Saponin Adjuvants in COVID-19 Vaccine","volume":"16","author":"Sharma","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 Spike Glycoprotein Vaccine Candidate NVX-CoV2373 Immunogenicity in Baboons and Protection in Mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1317410","article-title":"A Critical Appraisal of 'Shingrix', a Novel Herpes Zoster Subunit Vaccine (HZ\/Su or GSK1437173A) for Varicella Zoster Virus","volume":"13","author":"Bharucha","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030222","article-title":"Natural and Synthetic Saponins as Vaccine Adjuvants","volume":"9","author":"Wang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/BF02866642","article-title":"Industrial Uses and Sustainable Supply Ofquillaja Saponaria (Rosaceae) Saponins","volume":"53","author":"Mart\u00edn","year":"1999","journal-title":"Economic Bot"},{"key":"B30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1348-0421.1992.tb02103.x","article-title":"The Protective Activity of Tea Catechins Against Experimental Infection by Vibrio Cholerae O1","volume":"36","author":"Toda","year":"1992","journal-title":"Microbiol Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1021\/tx990003t","article-title":"Antioxidant Chemistry of Green Tea Catechins. Identification of Products of the Reaction of (-)-Epigallocatechin Gallate With Peroxyl Radicals","volume":"12","author":"Valcic","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb743","article-title":"A Receptor for Green Tea Polyphenol EGCG","volume":"11","author":"Tachibana","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12009","article-title":"Anti-Infective Properties of Epigallocatechin-3-Gallate (EGCG), a Component of Green Tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral Effect of Catechins in Green Tea on Influenza Virus","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02469","article-title":"Green Tea Catechin-Inactivated Viral Vaccine Platform","volume":"8","author":"Lee","year":"2017","journal-title":"Front Microbiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700747RR","article-title":"Harnessing an RNA-Mediated Chaperone for the Assembly of Influenza Hemagglutinin in an Immunologically Relevant Conformation","volume":"32","author":"Yang","year":"2018","journal-title":"FASEB J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jviromet.2013.10.035","article-title":"High-Yield Soluble Expression of Recombinant Influenza Virus Antigens From Escherichia Coli and Their Potential Uses in Diagnosis","volume":"196","author":"Jang","year":"2014","journal-title":"J Virol Methods"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(83)90062-7","article-title":"Mouse IgG Antibodies Have Subclass Associated Affinity Differences","volume":"20","author":"Sarvas","year":"1983","journal-title":"Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: A Novel FcR With Distinct IgG Subclass Specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014515107","article-title":"FcgammaRIV Deletion Reveals Its Central Role for IgG2a and IgG2b Activity In Vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.1961","article-title":"Gel Filtration Chromatography as a Method for Removing Bacterial Endotoxin From Antibody Preparations","volume":"30","author":"London","year":"2014","journal-title":"Biotechnol Prog"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nri2868","article-title":"Vaccine Delivery: A Matter of Size, Geometry, Kinetics and Molecular Patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.05.004","article-title":"Virus-Induced Humoral Immunity: On How B Cell Responses Are Initiated","volume":"3","author":"Zabel","year":"2013","journal-title":"Curr Opin Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120650","article-title":"RNA-Assisted Self-Assembly of Monomeric Antigens Into Virus-Like Particles as a Recombinant Vaccine Platform","volume":"269","author":"Hwang","year":"2021","journal-title":"Biomaterials"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.04.006","article-title":"Particulate Vaccines: On the Quest for Optimal Delivery and Immune Response","volume":"16","author":"De Temmerman","year":"2011","journal-title":"Drug Discov Today"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1437","article-title":"EGCG Redirects Amyloidogenic Polypeptides Into Unstructured, Off-Pathway Oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2012.01.013","article-title":"Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Abeta Oligomers","volume":"421","author":"Lopez del Amo","year":"2012","journal-title":"J Mol Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-007-9112-1","article-title":": In Vitro and In Vivo Anti-Allergic Effects of 'Benifuuki' Green Tea Containing O-Methylated Catechin and Ginger Extract Enhancement","volume":"55","author":"Maeda-Yamamoto","year":"2007","journal-title":"Cytotechnology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease","volume":"10","author":"van Erp","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 Gp120-Specific Antibody-Dependent Cell-Mediated Cytotoxicity Correlates With Rate of Disease Progression","volume":"157","author":"Baum","year":"1996","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e17377","DOI":"10.1371\/journal.pone.0017377","article-title":"A Protective Role for Complement C3 Protein During Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection","volume":"6","author":"O'Brien","year":"2011","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129520","article-title":"Selective Induction of Antibody Effector Functional Responses Using MF59-Adjuvanted Vaccination","volume":"130","author":"Boudreau","year":"2020","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2021.1907343","article-title":"Targeting Fc Effector Function in Vaccine Design","volume":"25","author":"Richardson","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2020.1801629","article-title":"Call for a Paradigm Shift in the Design of Universal Influenza Vaccines by Harnessing Multiple Correlates of Protection","volume":"15","author":"Jang","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3443","article-title":"Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Require FcgammaR Interactions for Protection Against Influenza Virus In Vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84428","article-title":"Broadly Neutralizing Anti-Influenza Antibodies Require Fc Receptor Engagement for In Vivo Protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.65","article-title":"IgG Subclass Co-Expression Brings Harmony to the Quartet Model of Murine IgG Function","volume":"94","author":"Collins","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/334255a0","article-title":"Regulation of Antibody Isotype Secretion by Subsets of Antigen-Specific Helper T Cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.054","article-title":"A Novel Adjuvant G3 Induces Both Th1 and Th2 Related Immune Responses in Mice After Immunization With a Trivalent Inactivated Split-Virion Influenza Vaccine","volume":"36","author":"Hjertner","year":"2018","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2165\/11206820-000000000-00000","article-title":"AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix(R)): A Review of Its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-540-92165-3_1","article-title":"Pandemic Influenza as a Current Threat","volume":"333","author":"Yen","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/v10090461","article-title":"The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses","volume":"10","author":"Sutton","year":"2018","journal-title":"Viruses"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-Radial-Immunodiffusion as an In Vitro Potency Assay for Human Inactivated Viral Vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.068","article-title":"Universal Monoclonal Antibody-Based Influenza Hemagglutinin Quantitative Enzyme-Linked Immunosorbent Assay","volume":"37","author":"Chae","year":"2019","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00896-14","article-title":"A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans","volume":"88","author":"Colpitts","year":"2014","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.769088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T01:33:15Z","timestamp":1673746395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.769088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2021.769088"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.769088","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"article-number":"769088"}}